DIN 02378299 — NUCYNTA IR 100 MG
NUCYNTA IR is a tablet (immediate-release) of Tapentadol marketed by KNIGHT THERAPEUTICS INC.. The full Tapentadol monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02378299
- Brand name
- NUCYNTA IR
- Active ingredient
- Tapentadol
- Strength
- 100 MG
- Dosage form
- TABLET (IMMEDIATE-RELEASE)
- Route
- ORAL
- Manufacturer
- KNIGHT THERAPEUTICS INC.
- Health Canada status
- MARKETED
- Drug class
- Opioid analgesic (mu-opioid receptor agonist and norepinephrine reuptake inhibitor)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Tapentadol products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02415585 | NUCYNTA EXTENDED-RELEASE | 100 MG | TABLET (EXTENDED-RELEASE) | KNIGHT THERAPEUTICS INC. | MARKETED |
| 02415593 | NUCYNTA EXTENDED-RELEASE | 150 MG | TABLET (EXTENDED-RELEASE) | KNIGHT THERAPEUTICS INC. | MARKETED |
| 02415607 | NUCYNTA EXTENDED-RELEASE | 200 MG | TABLET (EXTENDED-RELEASE) | KNIGHT THERAPEUTICS INC. | MARKETED |
| 02415615 | NUCYNTA EXTENDED-RELEASE | 250 MG | TABLET (EXTENDED-RELEASE) | KNIGHT THERAPEUTICS INC. | MARKETED |
| 02415577 | NUCYNTA EXTENDED-RELEASE | 50 MG | TABLET (EXTENDED-RELEASE) | KNIGHT THERAPEUTICS INC. | MARKETED |
| 02378272 | NUCYNTA IR | 50 MG | TABLET (IMMEDIATE-RELEASE) | KNIGHT THERAPEUTICS INC. | MARKETED |
| 02378280 | NUCYNTA IR | 75 MG | TABLET (IMMEDIATE-RELEASE) | KNIGHT THERAPEUTICS INC. | MARKETED |